2.35
                                            Schlusskurs vom Vortag:
              $2.46
            Offen:
              $2.41
            24-Stunden-Volumen:
                50,795
            Relative Volume:
              0.11
            Marktkapitalisierung:
                $110.84M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              -6.75%
            1M Leistung:
              +7.31%
            6M Leistung:
                -74.84%
            1J Leistung:
              +0.00%
            Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Vergleichen Sie ZYBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                ZYBT
                            
                             Zhengye Biotechnology Holding Ltd | 2.35 | 116.58M | 0 | 0 | 0 | 0.00 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 | 
Zhengye Biotechnology Holding Ltd Aktie (ZYBT) Neueste Nachrichten
How Zhengye Biotechnology Holding Limited stock benefits from global expansionBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Quantitative breakdown of Zhengye Biotechnology Holding Limited recent moveInflation Watch & Reliable Intraday Trade Plans - newser.com
Using data filters to optimize entry into Zhengye Biotechnology Holding LimitedJuly 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Can swing trading help recover from Zhengye Biotechnology Holding Limited losses2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com
Will Zhengye Biotechnology Holding Limited stock beat EPS estimatesJuly 2025 Price Swings & Verified Entry Point Signals - newser.com
Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) 26% Share Price Surge Not Quite Adding Up - simplywall.st
What earnings revisions data tells us about Zhengye Biotechnology Holding LimitedWeekly Trend Recap & Verified Short-Term Trading Plans - newser.com
Should you hold or exit Zhengye Biotechnology Holding Limited nowBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Can Zhengye Biotechnology Holding Limited stock maintain growth trajectory2025 Price Targets & Verified Chart Pattern Trade Signals - newser.com
Why Zhengye Biotechnology Holding Limited stock is a value investor pick2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
What Wall Street predicts for Zhengye Biotechnology Holding Limited stock priceRisk Management & Daily Risk Controlled Trade Plans - newser.com
How Zhengye Biotechnology Holding Limited stock performs in rising dollar environmentJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Zhengye Biotechnology Holding Limited recovery potential after sell offWeekly Investment Report & Verified Swing Trading Watchlist - newser.com
Published on: 2025-10-27 01:30:27 - newser.com
Is Zhengye Biotechnology Holding Limited a candidate for recovery playIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Is Zhengye Biotechnology Holding Limited stock entering bullish territory - newser.com
Published on: 2025-10-24 17:40:55 - newser.com
Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Challenges in the Veterinary Vaccine Market - DirectorsTalk Interviews
Is Zhengye Biotechnology Holding Limited showing signs of accumulationFed Meeting & Risk Managed Investment Entry Signals - newser.com
Published on: 2025-10-20 20:02:44 - newser.com
Evaluating Zhengye Biotechnology Holding Limited with trendline analysis2025 Short Interest & Verified Technical Signals - newser.com
What is the fair value of Zhengye Biotechnology Holding Limited stock now2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Nasdaq Moves: Why retail investors favor Zhengye Biotechnology Holding Limited stockJuly 2025 Macro Moves & Breakout Confirmation Alerts - Trung tâm Dự báo KTTV quốc gia
Is Zhengye Biotechnology Holding Limited stock ready for a breakoutMarket Trend Review & Low Drawdown Trading Techniques - newser.com
Zhengye Biotechnology Holding L (ZYBT): Navigating Challenges with Free Cash Flow Strength - DirectorsTalk Interviews
Zhengye Biotechnology (NASDAQ:ZYBT) Given Sell (D-) Rating at Weiss Ratings - Defense World
Smart tools for monitoring Zhengye Biotechnology Holding Limited’s price action2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-10 09:03:01 - newser.com
Zhengye Biotechnology (NASDAQ:ZYBT) Trading Down 11.7%Time to Sell? - MarketBeat
How Zhengye Biotechnology Holding Limited stock performs in weak economyEarnings Risk Report & Consistent Return Strategy Ideas - newser.com
Zhengye Biotechnology (ZYBT): Navigating Opportunities and Challenges in the Veterinary Vaccine Market - DirectorsTalk Interviews
Finanzdaten der Zhengye Biotechnology Holding Ltd-Aktie (ZYBT)
        Es liegen keine Finanzdaten für Zhengye Biotechnology Holding Ltd (ZYBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App